PATRIN PHARMA, Inc, is a privately held specialty pharmaceutical development company founded in 2005. The company focuses on the rapid development and commercialization of drugs in a niche market with innovative drug delivery systems. PATRIN PHARMA, Inc utilizes existing approved chemical entities, and hence expedite the clinical trial and FDA approval process. The company develops its own proprietary delivery systems and also actively license delivery technology platform and/or product candidates that fit its pipeline strategy.